Senior Director, US Medical, Lymphoma/CLL

Working with Us
Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams rich in diversity. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us.

Position Summary

The Senior Medical Director, US Lymphoma/CLL will report to the Executive Director, US Medical Multiple Myeloma/Lymphoma Disease Lead. He/she will be headquarter based, and will lead the team of physicians (MDs), Pharmacists and scientists providing scientific/medical leadership and support for approved products in Lymphoma Therapeutic Area as well as compounds in various stages of clinical development with priority focus on the Celmods and Nivolumab. This individual will be involved in integrated strategic planning within US Medical under the direction of the US Medical MM/Lymphoma Disease lead as well as with partners in WW Medical, WW commercial, Clinical Research and Development, Regulatory, Translational Development, and Market Access, and will lead the US medical Lymphoma team supporting the MM/Lymphoma Disease Lead.

The Senior Medical Director will provide key contribution for the overall medical strategy in the US, in alignment with overall US and World Wide Medical strategy, and will be responsible for execution of the medical plan for the therapeutic area under the direction of the Disease Lead. He/she will represent US Medical in lymphoma with broad responsibilities and impact across the US business and overall Medical organization. Execution of the strategy will be achieved through direct management of the Lymphoma team comprising of MDs, Pharmacists and scientists in their therapeutic area, execution of data generation including supporting BMS-sponsored medical-led trials and book of work related to investigator sponsored studies and collaborations, and coordination with the rest of the US Medical team including functional leaders and the field-based team. He/she will work closely with the World Wide Medical Lymphoma team to prepare for the US launch of new products, as appropriate.

Key Responsibilities

Essential Function, but not limited to:

Medical Affairs Strategy and Alignment

• Strategic and Tactical Planning: Responsibility for the Medical Affairs aspects of plans across Lymphoma in alignment with with US Disease Lead and with WW Medical plans, and their timely updates. Providing oversight, strategic direction, and ensuring appropriate cross-functional partnerships, e.g. use of resources and performance towards goals across:

• Launch plans for new products or new indication launches

• Publication plans

• Budget management of Lymphoma team’s tactics and deliverables in alignment and support of the Disease Lead.

• Medical affairs enabling functions, e.g. medical information letters, scientific educational grant requests and patient advocacy grant requests.

• Provide leadership, accountability, and focus across the Medical Affairs Disease sub-teams in Lymphoma which include Medical Directors, Pharmacists, Scientific Directors, Scientific Communications, Medical Education, Training and Staff Development, Medical Affairs Learning and Staff Development, MSL leadership, and other functions.

• Provide accountability and support the Disease sub-teams in executing Medical Affairs-led BMS-sponsored clinical trials, within appropriate standards for compliance, quality, timeliness, and budget. Support the team leads in the design, execution, and evaluation of clinical trials according to strategy and good clinical practice.

• Drive execution of data generation efforts to support both Lymphoma inline and pipeline products through registries, digital health and intervention studies, e.g. provide oversight across the ISR ( Investigator sponsored research) studies within the therapeutic area in the US: provide accountability and support in the integration o